Management of Polycystic Ovary Syndrome (PCOS)
Multicomponent lifestyle intervention—combining dietary modification, structured physical activity, and behavioral strategies—is the mandatory first-line treatment for all women with PCOS, regardless of body weight, because insulin resistance affects both lean and overweight patients and drives the core pathophysiology of hyperandrogenism, anovulation, and metabolic dysfunction. 1, 2
Understanding the Pathophysiology
Insulin resistance is present in all PCOS phenotypes, independent of BMI, affecting both lean and overweight women equally. 1, 2 Hyperinsulinemia compensates for this resistance and directly amplifies androgen production through effects on the pituitary (increasing LH secretion), liver (reducing sex hormone-binding globulin), and ovaries (stimulating theca cell androgen synthesis). 1 This creates a vicious cycle where obesity worsens insulin resistance, which worsens hyperandrogenism, which further impairs ovulation. 1
Critical pitfall: Do not dismiss lifestyle intervention in lean PCOS patients simply because they have normal BMI—insulin resistance requires management regardless of weight. 1
First-Line Lifestyle Intervention
Dietary Management
For women with elevated BMI: Create a daily energy deficit of 500–750 kcal (target total intake 1,200–1,500 kcal/day) to achieve 5–10% weight loss within 6 months. 1, 2, 3 This modest weight reduction produces clinically meaningful improvements in insulin resistance, ovulation frequency, fertility potential, circulating androgen concentrations, and reduces long-term endometrial cancer risk. 1
For all women (including normal-weight): No specific diet type is superior; any balanced dietary approach creating an energy deficit is acceptable. 1, 2, 3 Focus on patient preferences and cultural needs while following general healthy eating principles. 1, 3 Recent evidence supports low glycemic index foods, high-fiber diets, omega-3 fatty acid-rich diets, ketogenic diets, Mediterranean diets, and anti-inflammatory diets for improving insulin sensitivity and hormonal balance. 1, 4
Avoid unduly restrictive or nutritionally unbalanced diets. 1 Women with PCOS commonly have suboptimal intake of magnesium, folic acid, zinc, and B-vitamin complex; routine assessment and supplementation of these micronutrients are recommended. 1 Incorporating legumes, whole grains, nuts, and seeds—food sources rich in myo-inositol—may aid in managing both cardiometabolic disturbances and reproductive dysfunction. 1
Physical Activity Prescription
Minimum target for weight maintenance and health: At least 150 minutes/week of moderate-intensity activity (brisk walking, cycling 8–15 km/h, low-impact aerobics, yoga) OR 75 minutes/week of vigorous-intensity activity (jogging/running, high-impact aerobics, competitive sports), performed in bouts of at least 10 minutes. 1, 2, 3
For weight loss: Increase to at least 250 minutes/week of moderate-intensity activities OR 150 minutes/week of vigorous-intensity activity. 1, 3
Resistance training: Include muscle-strengthening activities involving major muscle groups on 2 non-consecutive days per week. 1, 2, 3
Daily activity goals: Target 10,000 steps daily, including at least 30 minutes of structured physical activity. 1 Minimize sedentary, screen, and sitting time throughout the day. 1, 3
Both aerobic and resistance exercises improve insulin sensitivity in PCOS, with benefits occurring independent of weight loss. 1, 3, 5 Exercise reduces fasting insulin by approximately 13 mU/L and fasting glucose by 0.8 mmol/L even in normal-weight women. 1
Behavioral Strategies
Implement SMART (Specific, Measurable, Achievable, Realistic, Timely) goal-setting with self-monitoring using fitness tracking devices for step count and exercise intensity. 1, 2, 3
Start with realistic 10-minute activity bouts and progressively increase total physical activity by 5% weekly. 1
Include comprehensive behavioral change techniques: goal-setting, stimulus control, problem-solving, assertiveness training, slower eating, positive reinforcement, and relapse prevention planning. 1, 2, 3
Psychological Screening and Support
This is critical and often overlooked: Screen all PCOS patients for anxiety, depression, body image concerns, and eating disorders (particularly binge-eating disorder and night-eating syndrome), which are highly prevalent in PCOS and dramatically reduce adherence to lifestyle interventions. 1, 2 These psychological factors create a vicious cycle worsening both obesity and hormonal disturbances. 1
Refer patients with moderately severe depression to psychiatry or behavioral health for evaluation and potential pharmacotherapy, as depression dramatically reduces adherence to lifestyle interventions. 1
Medical Management
For Women NOT Attempting to Conceive
Combined oral contraceptives (COCs) are first-line hormonal therapy for women not attempting conception, as they suppress ovarian androgen secretion, increase sex hormone-binding globulin, regulate menstrual cycles, prevent endometrial hyperplasia, and reduce hirsutism and acne. 1, 2, 6 A typical regimen is drospirenone 3 mg/ethinyl estradiol 20 μg in a 24-active/4-inert pill regimen, taken daily. 1
Metformin 500–2,000 mg daily (starting at 500 mg and titrating to 1,000–2,000 mg in divided doses) improves glucose tolerance over time and may have a positive impact on risk factors for diabetes and cardiovascular disease in women with cardiometabolic features such as abdominal obesity and insulin resistance. 1, 2, 6
For hirsutism: Combined medical interventions (antiandrogen plus ovarian suppression agent) may be most effective. 1, 6
GLP-1 receptor agonists (liraglutide 1.8–3 mg daily, semaglutide 1–2 mg weekly, or exenatide 5–10 μg twice daily or 2 mg weekly) in combination with lifestyle interventions can improve weight loss and metabolic control. 1
For Women ATTEMPTING to Conceive
Clomiphene citrate is first-line pharmacological treatment for ovulation induction, with approximately 80% of patients ovulating and 50% conceiving. 1, 6 Weight control and regular exercise programs should be started before medication. 1
Metformin 1 g twice daily for 12 weeks or until pregnancy can be used in the pregestational stage to improve fertility outcomes. 1
If clomiphene treatment fails, low-dose gonadotropin therapy should be used, which induces a high rate of monofollicular development with lower risk of ovarian hyperstimulation. 1
Monitoring and Follow-Up
Conduct fortnightly review for the first 3 months with structured dietary and physical activity plans, and regular review for the first 12 months to ensure adherence and adjust interventions. 1
Regularly monitor weight and waist circumference throughout both weight-loss and maintenance phases. 1, 3
Special Population Considerations
Ethnic-specific thresholds: Apply ethnicity-adjusted BMI and waist-circumference thresholds for Asian, Hispanic, and South Asian populations, who experience heightened cardiometabolic risk at lower cut-offs and require greater consideration for lifestyle intervention. 1, 3
Adolescents: Prevention of weight gain and monitoring should begin from adolescence, as weight gain escalates from this period. 1, 3 Adolescents should aim for at least 60 minutes of moderate-to-vigorous intensity physical activity daily, including muscle- and bone-strengthening activities at least 3 times weekly. 1
Family support: Design lifestyle activities that align with women's family routines, cultural preferences, and socioeconomic circumstances; family support enhances adherence and outcomes. 1
Critical Clinical Pearls
Even in the absence of measurable weight loss, adherence to a healthy lifestyle yields improvements in quality of life, metabolic health, and overall well-being. 1, 3
Ensure health professional interactions are respectful and patient-centered, avoiding weight-related stigma, which negatively impacts treatment engagement. 1, 3
Central obesity increases progressively with age; waist-to-hip ratio rises steadily between ages 20–45 years, highlighting the importance of early and sustained lifestyle intervention. 1, 3